PHGE Valuation

Biomx Inc

Add to Watchlist

Advanced Chart

0.541

+0.021(4.038%)1D

Overview
Forecast
Valuation
Earnings

PHGE Relative Valuation

PHGE's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PHGE is overvalued; if below, it's undervalued.

Historical Valuation

Biomx Inc (PHGE) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.72. The fair price of Biomx Inc (PHGE) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：0.51

Fair

-0.42

Trailing

Forward

-0.70

EV/EBITDA

Biomx Inc. (PHGE) has a current EV/EBITDA of -0.70. The 5-year average EV/EBITDA is -0.63. The thresholds are as follows: Strongly Undervalued below -2.67, Undervalued between -2.67 and -1.65, Fairly Valued between 0.39 and -1.65, Overvalued between 0.39 and 1.41, and Strongly Overvalued above 1.41. The current Forward EV/EBITDA of -0.70 falls within the Historic Trend Line -Fairly Valued range.

-0.78

EV/EBIT

Biomx Inc. (PHGE) has a current EV/EBIT of -0.78. The 5-year average EV/EBIT is -0.71. The thresholds are as follows: Strongly Undervalued below -2.93, Undervalued between -2.93 and -1.82, Fairly Valued between 0.40 and -1.82, Overvalued between 0.40 and 1.50, and Strongly Overvalued above 1.50. The current Forward EV/EBIT of -0.78 falls within the Historic Trend Line -Fairly Valued range.

0.00

Biomx Inc. (PHGE) has a current PS of 0.00. The 5-year average PS is 14.90. The thresholds are as follows: Strongly Undervalued below -85.27, Undervalued between -85.27 and -35.19, Fairly Valued between 64.98 and -35.19, Overvalued between 64.98 and 115.07, and Strongly Overvalued above 115.07. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Biomx Inc. (PHGE) has a current P/OCF of 0.00. The 5-year average P/OCF is -0.52. The thresholds are as follows: Strongly Undervalued below -3.39, Undervalued between -3.39 and -1.96, Fairly Valued between 0.92 and -1.96, Overvalued between 0.92 and 2.36, and Strongly Overvalued above 2.36. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

Biomx Inc. (PHGE) has a current P/FCF of 0.00. The 5-year average P/FCF is -0.89. The thresholds are as follows: Strongly Undervalued below -5.30, Undervalued between -5.30 and -3.10, Fairly Valued between 1.32 and -3.10, Overvalued between 1.32 and 3.53, and Strongly Overvalued above 3.53. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Biomx Inc (PHGE) has a current Price-to-Book (P/B) ratio of 28.14. Compared to its 3-year average P/B ratio of 1.47 , the current P/B ratio is approximately 1814.87% higher. Relative to its 5-year average P/B ratio of 1.58, the current P/B ratio is about 1681.12% higher. Biomx Inc (PHGE) has a Forward Free Cash Flow (FCF) yield of approximately -211.02%. Compared to its 3-year average FCF yield of -225.47%, the current FCF yield is approximately -6.41% lower. Relative to its 5-year average FCF yield of -154.76% , the current FCF yield is about 36.35% lower.

26.70

P/B

Median3y

1.47

Median5y

1.58

-201.01

FCF Yield

Median3y

-225.47

Median5y

-154.76

Competitors Valuation Multiple

The average P/S ratio for PHGE's competitors is 0.13, providing a benchmark for relative valuation. Biomx Inc Corp (PHGE) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Calidi Biotherapeutics Inc

Intensity Therapeutics Inc

Loss

14.78M

ADAP.O

Adaptimmune Therapeutics PLC

0.30

-89.33%

15.51M

Performance Decomposition

Market capitalization of PHGE increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of PHGE in the past 1 year is driven by Unknown.